A simplified procedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I
Am. Kalergis et al., A simplified procedure for the preparation of MHC/peptide tetramers: chemical biotinylation of an unpaired cysteine engineered at the C-terminus of MHC-I, J IMMUNOL M, 234(1-2), 2000, pp. 61-70
Recently, a powerful approach for the detection of MHC/peptide-specific T c
ells has been made possible by the engineering of soluble-tetrameric MHC/pe
ptide complexes, consisting of singly biotinylated MHC/peptide molecules bo
und to fluorescent-labeled streptavidin. These tetrameric molecules are tho
ught to compensate for the low affinity and relative fast dissociation rate
of the TCR/MHC-peptide interaction by increasing the avidity of this inter
action, thus allowing the stable binding of MHC/peptide tetramers to TCR ex
pressing cells. Here we describe a new more simplified procedure for obtain
ing MHC/peptide tetramers using the well-characterized H-2K(b)/VSV system.
This procedure consists of the incorporation of an unpaired cysteine residu
e at the C-terminus of the H-2K(b) molecule, allowing site-specific biotiny
lation by a -SH-specific biotinylating reagent. The H-2K(b)/VSV tetramers b
ound only to hybridomas expressing H-2K(b)/VSV-specific TCRs. When coated o
n a plate, these tetramers were able to induce IL-2 release by those hybrid
omas. Furthermore, H-2K(b)/VSV tetramers bound to CTL populations obtained
from mice immunized with VSV-peptide. The specificity of the binding was fu
rther refined by studying cross-recognition of VSV by CTL populations obtai
ned from mice immunized with single amino acid substituted VSV peptide vari
ants. H-2K(b)/VSV tetramers bound only to those CTL populations that cross-
reacted with the wild-type VSV peptide. Our method provides a simple, effic
ient and inexpensive procedure for making MHC/peptide tetramers, a highly s
pecific and very useful reagent with a number of important applications in
basic and clinical T cell research. (C) 2000 Elsevier Science B.V. All righ
ts reserved.